Next, we compared AD/G9a-corregulated proteins identified in 5xFAD/APP-NLGF mice with “modules” (M) of co-expressed proteins showing dysregulation in brains of AD patient 11 to identify 204 entities (51 proteins, 204 phosphoproteins) with AD-related, MS1262-reversed expression changes (Fig. 7E). This evidence concerns the gene APP and Alzheimer disease.